Skip Nav Destination
Close
Article navigation
Articles|
April 2012
The Latest in MH, From MHAUS
Sharon J. Hirshey Dirksen, Ph.D.;
Sharon J. Hirshey Dirksen, Ph.D.
Search for other works by this author on:
Marilyn Green Larach, M.D., FAAP;
Marilyn Green Larach, M.D., FAAP
Search for other works by this author on:
Henry Rosenberg, M.D.
Henry Rosenberg, M.D.
President
Malignant Hyperthermia Association of the United States
Search for other works by this author on:
ASA Newsletter April 2012, Vol. 76, 42–68.
Citation
Sharon J. Hirshey Dirksen, Marilyn Green Larach, Henry Rosenberg; The Latest in MH, From MHAUS. ASA Newsletter 2012; 76:42–68
Download citation file:
Close
Sign in
ASA members enjoy complimentary access to ASA publications, as well as a variety of educational resources. Join today!
ASA Members and Registered Users
Sign InInstitutional Administrators
Admin PortalPay-Per-View Access
$20.00
Advertisement
0
Views
0
Citations
Email alerts
Related Articles
Induction of Malignant Hyperthermia in Susceptible Swine by 3,4-Methylenedioxymethamphetamine (“Ecstasy”)
Anesthesiology (November 2003)
ATX II, A Sodium Channel Toxin, Sensitizes Skeletal Muscle to Halothane, Caffeine, and Ryanodine
Anesthesiology (May 1999)
Autosomal Dominant Canine Malignant Hyperthermia Is Caused by a Mutation in the Gene Encoding the Skeletal Muscle Calcium Release Channel ( RYR1 )
Anesthesiology (September 2001)
An Assessment of Penetrance and Clinical Expression of Malignant Hyperthermia in Individuals Carrying Diagnostic Ryanodine Receptor 1 Gene Mutations
Anesthesiology (November 2019)
Accuracy of Malignant Hyperthermia Diagnoses in Hospital Discharge Records
Anesthesiology (January 2015)
Advertisement
